1. The use of the exploratory IND in the evaluation and development of 18F-PET radiopharmaceuticals for amyloid imaging in the brain: a review of one company’s experience;Carpenter;Q. J. Nucl. Med. Mol. Imaging,2009
2. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain;Choi;J. Nucl. Med.,2009
3. Department of Health, Executive Yuan, R.O.C. (Taiwan). The guidance for manufacturing and dispensing of PET radiopharmaceuticals, December 29, 2003.
4. Current good manufacturing practice for positron emission tomography;Food and Drug Administration, HHS;Fed. Regist.,2009
5. PET imaging of amyloid deposition in patients with mild cognitive impairment;Forsberg;Neurobiol. Aging,2008